Researchers report the results obtained from the use of a new PRS calculator called CT-SLEB on a multi-national GWAS database.
Menu
Gritgen will begin production of its Phase III clinical and commercial product for haemophilia A. Credit: Sergey Kolesnikov/Shutterstock.com. Gritgen Therapeutics has launched operations at its
LONDON — Medicare’s first-ever drug pricing negotiations are officially underway. But neither government officials nor drugmakers are wanting to show their cards, at least publicly.